問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Thoracic Medicine
下載
2023-03-27 - 2029-07-30
Condition/Disease
Test Drug
Participate Sites6Sites
Not yet recruiting5Sites
Recruiting1Sites
2023-07-01 - 2027-11-30
Participate Sites10Sites
Not yet recruiting8Sites
Recruiting2Sites
2023-07-01 - 2027-04-20
Participate Sites5Sites
Not yet recruiting4Sites
2020-09-22 - 2024-03-29
Participate Sites7Sites
Terminated7Sites
2025-10-31 - 2029-06-26
Moderate-to-severe COPD
Injection
Participate Sites8Sites
2021-10-01 - 2027-12-31
Recruiting7Sites
2021-04-06 - 2026-05-08
Recruiting6Sites
2021-07-27 - 2026-09-30
xxxxxx
Participate Sites13Sites
Recruiting13Sites
2020-01-06 - 2026-09-05
Non-Small Cell Lung Cancer
Selpercatinib (LY3527723)
Participate Sites14Sites
Recruiting14Sites
2025-04-01 - 2032-12-31
Non–small cell lung cancer (NSCLC)
Durvalumab Olomorasib Pembrolizumab
Participate Sites18Sites
Recruiting18Sites
全部
